Paul Roethle

Paul Roethle's work experience begins in 2003 when they worked as a Graduate Student at the University of California, Berkeley. During this time, they completed various projects including the total synthesis of bipinnatin J and the bioactive natural product archazolid B. Paul also worked towards the asymmetric synthesis of azaphilone natural products and plumarellide.

In 2008, Roethle joined Gilead Sciences as a Research Scientist II, where they played a key role in planning, designing, implementing, and analyzing laboratory experiments for drug development projects related to liver diseases and antivirals. Paul also provided data analysis, led discussions on team issues, and proposed solutions.

After seven years at Gilead Sciences, Roethle became a Senior Manager in Project and Portfolio Management. In this role, they facilitated and managed the design, implementation, and update of project development plans for global and pediatric programs within the liver disease therapeutic area.

In 2015, Roethle took on two new ventures. Paul founded and became the CEO of Peridot Labs and also worked as a Principal Scientist at Constance Therapeutics.

Most recently, in 2017, Roethle founded CHEMISTRY. where they currently serve as both the Founder and CEO.

Paul Roethle completed their Bachelor of Science degree in Chemistry at the University of Wisconsin-Madison from 1999 to 2003. Paul then pursued their Ph.D. in Organic Chemistry at the University of California, Berkeley from 2003 to 2008.